NCT06930365

Clinical-Instrumental Study To Evaluate And Compare The Efficacy And Tolerability Of Two Emollients Products In Atopic Dermatitis

Clinical-Instrumental Study To Evaluate And Compare The Efficacy And Tolerability Of Two Emollients Products (Investigational Product Versus Placebo) In Atopic Dermatitis

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 64 (estimated)
• Sponsor: NAOS Les Laboratoires · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Atopic dermatitis (AD) is a chronic inflammatory skin disease associated with erythema, scaly and oozing plaques, and severe pruritus which has an important impact on quality of life and quality of sleep. It is divided into 2 chronic phases : flare-up and remission period. Signs and symptoms of AD are associated with a compromised immune system, a defective skin barrier, a cutaneous dysbiosis and overall inflammatory status. The aim of the study is to evaluate and compare the efficacy and tolerability of two face and body cream products, new emollient versus placebo, in used over the course of 5 weeks as a replacement of usual or any emollient by female and male subjects with atopic dermatitis. This is an interventional, single-center, double-blind, randomized and comparative study.

Conditions

• Atopic Dermatitis
• Eczema

Interventions

Type	Name	Description
OTHER	Anti-itching and repairing treatment. Emollient.	Anti-itching and repairing treatment. Emollient.
OTHER	Emollient cream	Emollient cream

Timeline

• Start date: 2024-12-09
• Primary completion: 2025-05-16
• Completion: 2025-07-18
• First posted: 2025-04-16
• Last updated: 2025-04-16

Locations

1 site across 1 country: Georgia